UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study

BMC cancer, 2022-09, Vol.22 (1), p.1-956, Article 956

2022

Volltextzugriff (PDF)

Working tables on Hormone Receptor positive (HR+), Human Epidermal growth factor Receptor 2 negative (HER2-) early stage breast cancer: Defining high risk of recurrence

Critical reviews in oncology/hematology, 2023-11, Vol.191, p.104104-104104, Article 104104

2023

Volltextzugriff (PDF)

Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study

Breast cancer research and treatment, 2016-12, Vol.160 (3), p.501-509

2016

Volltextzugriff (PDF)

The effect of metformin on apoptosis in a breast cancer presurgical trial

British journal of cancer, 2013-11, Vol.109 (11), p.2792-2797

2013

Volltextzugriff (PDF)

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

Annals of oncology, 2013-02, Vol.24 (2), p.454-462

2013

Volltextzugriff (PDF)

Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients

Annals of oncology, 2012-12, Vol.23 (12), p.3116-3122

2012

Volltextzugriff (PDF)

Breast cancer in elderly women: a different reality? Results from the NORA study

Annals of oncology, 2007-06, Vol.18 (6), p.991-996

2007

Volltextzugriff (PDF)

Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer

Annals of oncology, 2011-03, Vol.22 (3), p.582-587

2011

Volltextzugriff (PDF)

Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study

European journal of neurology, 2013-05, Vol.20 (5), p.788-794

2013

Volltextzugriff (PDF)

Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials

Annals of oncology, 2014-03, Vol.25 (3), p.618-623

2014

Volltextzugriff (PDF)

Comment on "Charge-density wave and superconducting dome in TiSe2 from electron-phonon interaction"

Physical review letters, 2014-01, Vol.112 (4), p.049701-049701

2014

Volltextzugriff (PDF)

Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?

International journal of breast cancer, 2017-01, Vol.2017 (2017), p.1-6

2017

Volltextzugriff (PDF)

A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study

Annals of oncology, 2013-11, Vol.24 (11), p.2753-2760

2013

Volltextzugriff (PDF)

Fulvestrant (FUL) as first-line therapy in HR+ve, HER2-ve advanced breast cancer (ABC) patients (pts): when clinical practice comes earlier than clinical trials. Results from the GIM-13 AMBRA study

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi32

2017

Volltextzugriff (PDF)

Nab-paclitaxel (Nab-P) in HER2-ve advanced breast cancer (ABC) patients (pts): focus on luminal cancers. Results from GIM13 - AMBRA study

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi34

2017

Volltextzugriff (PDF)

Efficacy and Safety of the All-Oral Schedule of Metronomic Vinorelbine and Capecitabine in Locally Advanced or Metastatic Breast Cancer Patients: The Phase I-II VICTOR-1 Study

International Journal of Breast Cancer, 2014-01, Vol.2014 (2014), p.184-190

2014

Volltextzugriff (PDF)

Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): old drugs, new results. The multicenter VICTOR-6 study

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi29

2017

Volltextzugriff (PDF)

From the CLEOPATRA study to real life: preliminary results from the G.O.N.O. SUPER trial

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi28-vi29

2017

Volltextzugriff (PDF)

Genomewide Association Study of Severe Covid-19 with Respiratory Failure

The New England journal of medicine, 2020-10, Vol.383 (16), p.1522-1534

2020

Volltextzugriff (PDF)

A Randomized Trial of Low-Dose Tamoxifen on Breast Cancer Proliferation and Blood Estrogenic Biomarkers

JNCI : Journal of the National Cancer Institute, 2003-06, Vol.95 (11), p.779-790

2003

Volltextzugriff (PDF)

Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study

Annals of oncology, 2013-07, Vol.24 (7), p.1859-1866

2013

Volltextzugriff (PDF)

From the trastuzumab era to new target therapies: beyond revolution

Annals of oncology, 2007-06, Vol.18 (suppl-6), p.vi1-vi4

2007

Volltextzugriff (PDF)

8C.04: POSSIBLE ROLE OF ARTERIAL FUNCTION IN CANCER TREATMENT TARGETING VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ONCOLOGIC RESPONSE

Journal of hypertension, 2015-06, Vol.33 Suppl 1 - ESH 2015 Abstract Book (Supplement 1), p.e111-e111

2015

Volltextzugriff (PDF)

Effect of Intravenous Tirofiban and Aspirin in Reducing Short-Term and Long-Term Neurologic Deficit in Patients with Ischemic Stroke: A Double-Blind Randomized Trial

Cerebrovascular diseases (Basel, Switzerland), 2010-02, Vol.29 (3), p.275-281

2010

Volltextzugriff (PDF)

Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study

Annals of oncology, 2010-05, Vol.21 (5), p.949-954

2010

Volltextzugriff (PDF)

1 – 25 von 1.055

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieEuropean Journal Of Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(903)
Mit Volltextzugriff
(881)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study

Working tables on Hormone Receptor positive (HR+), Human Epidermal growth factor Receptor 2 negative (HER2-) early stage breast cancer: Defining high risk of recurrence

Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study

The effect of metformin on apoptosis in a breast cancer presurgical trial

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients

Breast cancer in elderly women: a different reality? Results from the NORA study

Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer

Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study

Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials

Comment on "Charge-density wave and superconducting dome in TiSe2 from electron-phonon interaction"

Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?

A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study

Fulvestrant (FUL) as first-line therapy in HR+ve, HER2-ve advanced breast cancer (ABC) patients (pts): when clinical practice comes earlier than clinical trials. Results from the GIM-13 AMBRA study

Nab-paclitaxel (Nab-P) in HER2-ve advanced breast cancer (ABC) patients (pts): focus on luminal cancers. Results from GIM13 - AMBRA study

Efficacy and Safety of the All-Oral Schedule of Metronomic Vinorelbine and Capecitabine in Locally Advanced or Metastatic Breast Cancer Patients: The Phase I-II VICTOR-1 Study

Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): old drugs, new results. The multicenter VICTOR-6 study

From the CLEOPATRA study to real life: preliminary results from the G.O.N.O. SUPER trial

Genomewide Association Study of Severe Covid-19 with Respiratory Failure

A Randomized Trial of Low-Dose Tamoxifen on Breast Cancer Proliferation and Blood Estrogenic Biomarkers

Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study

From the trastuzumab era to new target therapies: beyond revolution

8C.04: POSSIBLE ROLE OF ARTERIAL FUNCTION IN CANCER TREATMENT TARGETING VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ONCOLOGIC RESPONSE

Effect of Intravenous Tirofiban and Aspirin in Reducing Short-Term and Long-Term Neurologic Deficit in Patients with Ischemic Stroke: A Double-Blind Randomized Trial

Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study

Aktive Filter

Suchergebnisse filtern